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Remarkable geographic variation exists in clinical prostate cancer
incidence. Annual age-adjusted incidence rates of approximately 1
per 100 000 are found in China and up to 102 per 100 000 in
USblacks. Rates for whites in the US vary from about 45 to 65 per
100 000. In Western Europe most incidence rates are around
20–30 per 100 000 although some variation exists (Parkin et al,
1992). The prevalence of latent prostatic carcinomas is estimated
to be similar in areas with high and with low total prostate cancer
incidence rates (Pienta and Esper, 1993; Boyle et al, 1995).
Because of these variations in incidence rates worldwide, environ-
mental factors, particularly dietary factors, are widely considered
to be related to prostate cancer risks (Mettlin, 1997). Consumption
of animal products such as meat, fish, milk, dairy products and
eggs differs between countries with high and low prostate cancer
incidence rates and may, therefore, be an explanation for the
observed differences in incidence rates.
Results from several cohort (Snowdon et al, 1984; Mills et al,
1989; Severson et al, 1989; Thompson et al, 1989; Hirayama,
1990; Hsing et al, 1990; Gann et al, 1994; Le Marchand et al,
1994; Giovannucci et al, 1995; Gronberg et al, 1996) and case-
control studies (Schuman et al, 1982; Graham et al, 1983; Mishina
et al, 1985; Talamini et al, 1986, 1992; Ross et al, 1987; Oishi et al,
1988; Mettlin et al, 1989; Bravo et al, 1991; Walker et al, 1992;
Andersson et al, 1995; Ewings and Bowie, 1996; Pawlega et al,
1996; Key et al, 1997) are available on consumption of animal
products and prostate cancer risk. However, the role of animal
products remains unclear since contradictory results from both
types of studies have been reported.
The effect of animal products on prostate cancer risk is often
attributed to their fat content (Pienta and Esper, 1993; Kolonel,
1996; Boyle and Zaridze, 1993; Giles and Ireland, 1997).
Increased fat intake might lead to increased testosterone levels and
this might, eventually, lead to increased cell division and activa-
tion of proto-oncogenes and deactivation of tumour suppressor
genes (Ross and Henderson, 1994). However, there is no conclu-
sive evidence on the role of fat in prostate cancer aetiology (Giles
and Ireland, 1997). Other hypotheses on the mechanism of action,
therefore, deserve consideration, such as that 1,25(OH)2D, which
is a vitamin D metabolite, levels are protective (Corder et al, 1993,
1995) and calcium intake of which dairy products are a major
dietary source, may increase prostate cancer risk by suppressing
1,25(OH)2D levels (Giovannucci et al, 1998). Another possibility
is that mutagenic heterocyclic amines, produced when meat is
burned at high temperatures, may be carcinogenic (Felton et al,
1997). It has been suggested that dietary factors may play a greater
role in accelerating tumour growth than in initiating cancer
(Kolonel, 1996; Giles and Ireland, 1997; Mettlin, 1997) but thus
far it is not clear whether this is true for animal products. We have
investigated animal products consumption as well as calcium
intake in relation to prostate cancer risk in the Netherlands Cohort
Study (NLCS); intake of protein (total, animal and vegetable) was
also evaluated.
MATERIALS AND METHODS
The cohort
The NLCS was initiated in September 1986 and has been
described in detail elsewhere (Van den Brandt et al., 1990a). The
male cohort consists of 58 279 men aged 55–69 years who
completed a self-administered questionnaire on usual diet, and
other risk factors for cancer. The case-cohort approach (Prentice,
1986) was used in which cases are derived from the entire cohort
(providing numerator information for calculation of cancer
incidence rates), while accumulated person years at risk in the total
cohort are estimated using a random subcohort sample (providing
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from the total cohort and consists of 1688 men. In the follow-up
for cancer described previously (Van den Brandt et al, 1990b),
incident prostate cancer cases were detected by computerized
record linkage with all nine cancer registries in The Netherlands,
and with the Dutch national data base of pathology reports
(PALGA). The subcohort has been followed up biennially for vital
status information. Completeness of cancer follow-up was at least
96% (Goldbohm et al, 1994b) and follow-up of person years in the
subcohort was complete. After a follow-up period of 6.3 years
(September 1986–December 1992), 704 incident, microscopically
confirmed, primary prostate cancer cases were detected. During
this period, systematic screening for prostate cancer was not used
in The Netherlands.
The questionnaire
Usual consumption of food and beverages during the year
preceding the start of the study was assessed with a 150-item semi-
quantitative food frequency questionnaire (Goldbohm et al,
1994a) including 14 different individual fresh meat items (several
cuts of beef and pork, minced meat, chicken, liver, other meat),
fish, 14 milk and milk items (whole, low-fat and skimmed milk,
cream, buttermilk, chocolate milk, dry curd, whole and skimmed
yogurt, other items) and eggs. For fresh meat items, participants
also had to indicate their usual amount of consumption in grams
(as bought, i.e. based on raw meat). For four cured meat items
(boiled ham, bacon, lean meat products including smoked beef,
and ‘other sliced cold meats’) and two cheese items (fat cheese and
low-fat cheese) subjects had to indicate how many slices of bread
they ate with the particular product on it. For other items, subjects
had to indicate the consumption amount in natural or household
units (e.g. glass). Mean daily consumption (g per day) of the items
was calculated by multiplying frequency of consumption by
amount of consumption with standard portion sizes for the items
that were asked in natural or household units. Calcium and protein
intake were computed using the computerized Dutch food compo-
sition table (Nevo Tabel, 1986). The questionnaire has been vali-
dated against a 9-day diet record. For the exposures under study
the Spearman correlation coefficients between questionnaire and
the dietary record were as follows: fresh meat 0.46, cured meat
0.54; milk and milk products 0.60; cheese 0.61; fish 0.53; eggs
0.61. The Pearson correlation coefficient (energy and sex-
adjusted) for calcium was 0.62 and for total protein, vegetable
protein and animal protein the estimates were 0.59, 0.68 and 0.64
respectively (Goldbohm et al, 1994a).
Data analysis
Subjects who reported a history of cancer at baseline, other than
skin cancer, were excluded. Furthermore, our criteria (Goldbohm
et al, 1994a), required exclusion of subjects with incomplete or
inconsistent dietary data; 642 men with prostate cancer and 1525
male subcohort members remained for analysis.
Intake of calcium and protein was adjusted for energy by regres-
sion analysis (Willett, 1990). Mean intake levels of the different
exposure variables and other characteristics were compared
between prostate cancer cases and male subcohort members.
Furthermore, mean intakes of fresh meat, fish, cured meat, milk
and milk products, cheese, eggs, calcium and protein were
compared in categories of potential confounders, namely age, a
family history of prostate cancer and socioeconomic status. Total
energy and total fat intake were not considered as potential
confounding factors because no association with prostate cancer
risk was observed in our study (data not shown). The same applies
to vegetable and fruit consumption (Schuurman et al, 1998).
Energy was, however, included in the analyses for calcium and
protein, whereas total protein was included in the analyses of
animal and vegetable protein to assess the substitution effects of
the two sources of protein. Rate ratios (RR) and 95% confidence
intervals (95% CI) were computed for quintiles or categories of
exposure variables, as well as for continuous variables, using the
GLIM statistical package (Baker, 1985). Exponentially distributed
survival times were assumed in the follow-up period. Since stan-
dard software was not available, specific macros were developed
to account for the additional variance introduced by using the
subcohort instead of the entire cohort (Volovics and van den
Brandt, 1997). Tests for trend were based on likelihood ratio tests.
Throughout this report two-sided P-values are used. Age-adjusted
and multivariate analyses were conducted. In order to evaluate the
independent contribution of each specific type of fresh meat, cured
meat and dairy items analyses were done with the inclusion of
total fresh meat, total cured meat and total dairy consumption,
respectively, in the multivariate models. Furthermore, analyses
were done for localized (T0–2, M0) and advanced (T3–4, M0;
T0–4, M1) prostate cancer cases separately. This classification is
based on the TNM staging system. To evaluate whether preclinical
symptoms may have influenced results, additional analyses with
exclusion of cases detected during the first 2 years of follow-up
were conducted.
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Table 1 Description of mean daily intake of animal products, protein and
calcium and other characteristics in prostate cancer cases and subcohort
members, Netherlands Cohort Study (1986–1992)
Characteristics Cases Subcohort
(n = 642) (n = 1525)
mean (s.d.) mean (s.d.)
Exposure variables (g per day)
Fresh meat and poultrya 102.9 (39.6) 105.2 (43.1)
Fish 15.0 (17.2) 14.2 (16.0)
Cured meatb 15.2 (15.0) 15.7 (17.3)
Milk and milk productsc 307.1 (190.1) 308.0 (215.0)
Cheesed 23.0 (18.7) 22.8 (19.4)
Eggs 16.5 (12.1) 17.1 (12.5)
Calcium (mg per day)e 951.7 (274.7) 943.7 (292.4)
Total proteine 75.3 (10.9) 75.4 (11.4)
Vegetable proteine 27.6 (6.0) 27.9 (6.0)
Animal proteine 48.2 (11.1) 48.1 (11.8)
Potential confounding variables
Age (years) 63.9 (3.8) 61.4 (4.2)
Family history of prostate cancer (% yes) 4.4 2.7
Highest educational level (%)f
Low 44.4 46.8
Medium 34.6 34.8
High 20.2 17.8
aThis includes beef, pork, minced meat (beef and pork), poultry, liver and
‘other meat’ (raw weight). bThis includes boiled ham, bacon, lean meat
products (including smoked beef) and ‘other sliced cold meats’ (several types
of sausages). cThis includes fermented milk products, and non-fermented
milk products. dThis includes fat cheese and low-fat cheese. eEnergy-
adjusted. fThere was missing information for 0.8% (cases) and 0.7%
(subcohort members); low is defined as primary school with/without lower
level vocational education, medium as secondary school or medium level
vocational education, high as university or higher level vocational education.RESULTS
The mean intake of fresh meat, fish, cured meat, milk and milk
products, cheese, eggs, calcium and protein among cases and
subcohort members is shown in Table 1. None of these food prod-
ucts differed markedly between cases and subcohort members in
main in the Table. The distribution of potential confounding
factors is also shown in Table 1. Cases are older than subcohort
members and more often have a positive family history of prostate
cancer. Furthermore, cases more often have a high socioeconomic
status compared to subcohort members. Consumption of cured
meat was highest among the youngest men and protein intake was
highest among men aged 60–64 years. Men in the lowest category
of socioeconomic status consumed more fresh meat, cured meat
and eggs, and less cheese. Men with a positive family history of
prostate cancer consumed more calcium than men without such a
family history. Mean consumption of animal products or protein
intake differed not between subjects with and without a family
history of prostate cancer (data not shown).
RRs for quintile or categorized variables for clusters of food
items are shown in Table 2. For total fresh meat and fish consump-
tion no associations with prostate cancer were observed. For both
total cured meat and milk and milk products a positive trend in risk
was observed (P-values for trend test were 0.04 and 0.02 respec-
tively). The RRs (95% CI) were 1.37 (1.00–1.89) for cured meat
and 1.12 (0.81–1.56) for milk and milk products for the highest
versus lowest quintile of consumption. Only the RR in the fourth
quintile of consumption of milk and milk products was signifi-
cantly increased (RR = 1.63, 95% CI 1.20–2.20). In the age-
adjusted analysis, consumption of cheese showed a positive trend
in risk (P = 0.04), this P-value was 0.09 in the multivariate analysis.
The RR for the highest versus the lowest category of consumption
was 1.21 (95% Cl 0.87–1.70). Egg consumption showed no associ-
ation with prostate cancer risk. After exclusion of cases diagnosed
in the first 2 years of follow-up, RRs were virtually the same.
Table 3 shows results for animal products evaluated as contin-
uous variables, for all tumours and separately for localized and
advanced prostate tumours. Within the cluster of fresh meat and
poultry items, none of the continuous variables was clearly associ-
ated with risk of prostate cancer. Also in subgroups of localized
and advanced prostate tumours mostly no association existed.
Only for consumption of liver an inverse association with
advanced prostate tumours was observed (RR per 5 g increment =
0.79, 95% CI 0.63–0.99). An item on horsemeat, lamb and mutton
and an item on consumption of veal were included in the other
meat category. The RR (95% CI) per 5 g for consumption of
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Table 2 Rate ratios (RRs) and 95% confidence intervals (95% CI) for prostate cancer according to quintiles or categories of consumption of meat, fish,
processed meat, milk and dairy, cheese and eggs, Netherlands Cohort Study (1986–1992)
Exposure Q1a Q2 Q3 Q4 Q5 P for trend
Fresh meat and poultry
Median intakeb 56 85 102 123 158
Cases/Person years 128/1820 138/1919 144/1787 121/1766 111/1830
RR (95% CI)c 1.00 1.08 (0.80–1.46) 1.23 (0.91–1.67) 1.05 (0.77–1.43) 1.01 (0.73–1.39) 0.98
RR (95% CI)d 1.00 1.08 (0.79–1.47) 1.27 (0.93–1.73) 1.12 (0.82–1.53) 1.07 (0.77–1.47) 0.52
Fish
Median intakeb,e 0 5 14 32
Cases/Person years 162/2238 135/2115 119/1874 226/2895
RR (95% CI)c 1.00 0.85 (0.64–1.13) 0.95 (0.70–1.28) 1.06 (0.82–1.37) 0.32
RR (95% CI)d 1.00 0.83 (0.62–1.11) 0.95 (0.70–1.29) 1.03 (0.80–1.34) 0.41
Cured meat
Median intakeb 0 5 11 19 36
Cases/Person years 118/1849 137/1907 140/1703 124/1880 123/1783
RR (95% CI)c 1.00 1.18 (0.87–1.61) 1.46 (1.07–1.99) 1.14 (0.84–1.57) 1.32 (0.96–1.81) 0.07
RR (95% CI)d 1.00 1.22 (0.90–1.67) 1.50 (1.09–2.06) 1.18 (0.86–1.62) 1.37 (1.00–1.89) 0.04
Milk and milk products
Median intakeb 74 179 271 376 566
Cases/Person years 114/1860 112/1835 132/1803 172/1824 112/1800
RR (95% CI)c 1.00 1.08 (0.79–1.49) 1.22 (0.89–1.67) 1.60 (1.19–2.17) 1.09 (0.79–1.50) 0.03
RR (95% CI)d 1.00 1.11 (0.80–1.53) 1.25 (0.91–1.71) 1.63 (1.20–2.20) 1.12 (0.81–1.56) 0.02
Cheese
Median intakeb 21 3 1 9 2 7 4 3
Cases/Person years 140/2261 121/1620 119/1607 175/2371 87/1264
RR (95% CI)c 1.00 1.29 (0.95–1.74) 1.16 (0.86–1.58) 1.34 (1.01–1.77) 1.26 (0.90–1.76) 0.04
RR (95% CI)d 1.00 1.27 (0.94–1.73) 1.15 (0.84–1.56) 1.28 (0.97–1.70) 1.21 (0.87–1.70) 0.09
Eggs
Median intakeb,e 51 4 2 9
Cases/Person years 197/2530 208/3243 237/3349
RR (95% CI)c 1.00 0.90 (0.70–1.15) 0.96 (0.76–1.22) 0.72
RR (95% CI)d 1.00 0.89 (0.69–1.14) 0.96 (0.75–1.22) 0.71
aReference category. bMedian intake (g per day) in subcohort; cut-points fresh meat and poultry 73, 93, 108, 137; fish 0, 10, 20; cured meat 2, 8, 14, 25; milk
and milk products 139, 220, 321, 460; cheese 7, 14, 21, 37; eggs 7, 14. cAdjusted for age. dAdjusted for age, family history of prostate cancer and
socioeconomic status. eCategories instead of quintiles.horsemeat, lamb and mutton was 1.11 (1.02–1.21) and 1.07
(0.99–1.15) for consumption of veal (data not shown). Total fish
and total cured meat consumption were not associated with overall
prostate cancer risk, or with risk of localized and advanced
tumours. Evaluated as continuous variables, none of the individual
cured meat items was strongly related to prostate cancer risk.
Nevertheless, in categorized analyses a positive trend in risk was
noted for consumption of ‘other sliced cold meats’ (P-value trend
test = 0.02). For the highest versus the lowest consumption cate-
gory a RR of 1.37 (95% CI 1.03–1.83) was found in the multi-
variate analysis. This increase in risk was only found in the
subgroup of localized prostate tumours (RR for the same contrast
= 1.44, 95% CI 0.95–2.20) and not for advanced prostate tumours
(data not shown). Fermented whole milk showed a borderline
significant inverse association with overall prostate cancer risk
(RR per 50 g = 0.87, 95% CI 0.76–1.00), and also for advanced
tumours an inverse association was suggested (RR per 50 g = 0.84,
95% CI 0.66–1.05). For none of the individual milk items except
consumption of whole yoghurt, associations with prostate cancer
risk were observed. In the continuous model, the RR for consump-
tion of whole yoghurt per 50 g increment was 0.88 (95% CI
0.76–1.01). Cheese consumption showed no association with
overall prostate cancer risk, but was positively associated with
localized prostate tumours (RR per 20 g = 1.20, 95% CI
1.06–1.37). Finally, consumption of eggs was inversely associated
with advanced prostate tumours (RR per 20 g = 0.70, 95% CI
0.53–0.93).
The results for calcium and protein intake are shown in Table 4.
For intake of calcium and total protein no associations with
prostate cancer risk were noted. Controlling for total protein,
intake of vegetable protein showed RR below one in all four cate-
gories, but none of the RRs was statistically significant. All RRs
for intake of animal protein were above one. Only the RR in the
fourth quintile of intake was statistically significant (RR = 1.52,
95% CI 1.01–2.30). For both sources of protein intake, no trend in
risk was found. We also examined calcium and protein intake in
subgroups of localized and advanced prostate tumours. As for the
animal products, there was no clear tendency for stronger associa-
tions with advanced prostate tumours.
DISCUSSION
Overall consumption of fresh meat and poultry, fish, cheese and
eggs showed no association with prostate cancer risk in the NLCS.
The observed positive trend in risk for quintiles of total cured meat
consumption could be explained by a positive association with
consumption of ‘other sliced cold meats’. For most clusters of
milk items, or individual milk items, no strong associations were
observed, but consumption of whole yoghurt might be associated
with a decreased prostate cancer risk. Intake of calcium and
protein was not associated with risk of prostate cancer in our study.
Finally, we found no clear evidence of a stronger association of
various products with advanced prostate cancer.
The NLCS is a prospective cohort study specifically designed to
evaluate the relation between diet and cancer. An important
strength of prospective studies is that recall bias is avoided
because of the prospective nature of these studies. Selection bias is
also not likely to have taken place because of the high complete-
ness of follow-up of subcohort members (Van den Brandt et al,
1993; Goldbohm et al, 1994b). A 150-item semi-quantitative food
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Table 3 Rate ratios (RRs) and 95% confidence intervals (95% CI) for prostate cancer for continuous variables of consumption of animal products, for all cases
and separately for localized (T0–2, M0) and advanced (T3–4, M0; T0–4, M1) tumours, Netherlands Cohort Study (1986–1992)
Exposure Intake in Increment All tumours Localized tumours Advanced
subcohort (n = 642) (n = 226) tumours
(g per day) (n = 213)
Mean (s.d.) RR (95% CI)a RR (95% CI)a RR (95% CI)a
Fresh meat and poultry 105.2 (43.1) 25 1.00 (0.86–1.16) 0.99 (0.91–1.08) 1.00 (0.91–1.09)
Beefb 27.4 (23.6) 25 1.00 (0.89–1.12) 0.95 (0.80–1.12) 0.92 (0.77–1.10)
Porkb 40.6 (31.1) 25 1.06 (0.96–1.18) 1.16 (1.00–1.34) 1.06 (0.91–1.23)
Minced meat (beef and pork)b 20.0 (19.0) 25 0.86 (0.74–1.01) 0.84 (0.66–1.07) 0.90 (0.71–1.14)
Chickenb 13.4 (15.0) 25 1.00 (0.84–1.18) 0.89 (0.68–1.16) 1.11 (0.87–1.42)
Liverb 2.1 (4.7) 5 0.92 (0.82–1.04) 0.99 (0.85–1.17) 0.79 (0.63–0.99)
Other meatb 2.8 (6.0) 5 1.06 (0.99–1.15) 1.04 (0.93–1.16) 1.09 (0.98–1.21)
Fish 14.2 (16.0) 25 1.06 (0.91–1.22) 0.91 (0.73–1.15) 1.08 (0.87–1.33)
Cured meat 15.7 (17.3) 15 1.03 (0.94–1.12) 1.03 (0.91–1.17) 1.00 (0.88–1.14)
Boiled hamc 5.4 (8.1) 15 0.94 (0.73–1.21) 1.00 (0.69–1.45) 0.95 (0.64–1.40)
Baconc 2.0 (5.1) 15 0.80 (0.57–1.13) 0.79 (0.47–1.33) 1.04 (0.66–1.65)
Lean meat productsc 2.4 (5.4) 15 0.93 (0.68–1.27) 0.78 (0.48–1.29) 1.01 (0.63–1.60)
Other sliced cold meatc 6.0 (10.2) 15 1.18 (0.96–1.44) 1.22 (0.90–1.65) 1.01 (0.74–1.39)
Milk and milk products 308.0 (215.0) 50 1.00 (0.98–1.03) 1.01 (0.98–1.05) 0.99 (0.95–1.03)
Whole milk, fermentedd 15.9 (40.1) 50 0.87 (0.76–1.00) 0.96 (0.79–1.15) 0.84 (0.66–1.05)
Low-fat milk, fermentedd 68.4 (107.5) 50 1.01 (0.96–1.07) 1.01 (0.94–1.09) 1.03 (0.95–1.11)
Whole milkd 136.0 (164.4) 50 1.00 (0.96–1.03) 0.97 (0.92–1.03) 1.00 (0.95–1.06)
Low-fat milkd 87.8 (139.4) 50 1.01 (0.97–1.05) 1.03 (0.97–1.09) 0.99 (0.93–1.06)
Cheese 22.8 (19.4) 20 1.02 (0.93–1.13) 1.20 (1.06–1.37) 0.92 (0.78–1.08)
Cheesee 21.1 (18.6) 20 0.99 (0.76–1.30) 0.94 (0.68–1.29) 1.05 (0.66–1.68)
Low-fat cheesee 1.7 (7.6) 20 1.01 (0.77–1.32) 1.07 (0.78–1.47) 0.95 (0.60–1.52)
Eggs 17.1 (12.5) 20 0.95 (0.81–1.11) 0.99 (0.78–1.24) 0.70 (0.53–0.93)
aAdjusted for age, family history of prostate cancer, and socioeconomic status. bAdditional adjustment for consumption of total fresh meat and poultry.
cAdditional adjustment for consumption of total cured meat. dAdditional adjustment for consumption of total milk and milk products. eAdditional adjustment for
consumption of total cheese.frequency questionnaire was used to estimate the usual consump-
tion of fresh meat and poultry, fish, cured meat, milk and milk
products, cheese and eggs during the year preceding the start of the
study. The questionnaire was validated against a 9-day dietary
record. Based on the Spearman correlation coefficients we
conclude that our exposure variables were reasonably well
measured. In addition, these correlation coefficients may be under-
estimated because many of the record data were coded as ingredi-
ents from recipes or mixed dishes as opposed to the questionnaire
data, which were coded as food product. Consequently, the divi-
sion between food groups was not always clear, resulting in lower
correlations (Goldbohm et al, 1994a). Misclassification of subjects
according to their exposure status is possible, but expected to
be non-differential. To prevent substantial misclassification of
subjects with respect to exposure status, subjects with incomplete
or inconsistent data were excluded, according to criteria published
before (Goldbohm et al, 1994a). Besides a validation study, five
annually repeated measurements of the food frequency question-
naire were conducted. From the results it was concluded that the
single measurement of diet in the NLCS can characterize dietary
habits for a period of at least 5 years (Goldbohm et al, 1995). This
is further supported by the fact that our study population consists
of older subjects (aged 55–69 years) with relatively stable dietary
habits (Van den Brandt et al, 1990a).
Data gathered with our questionnaire allowed us to take other
dietary and non-dietary risk factors for prostate cancer into
account in multivariate analyses. Although our final multivariate
model was also somewhat restricted, we considered several poten-
tial confounding factors and only those factors associated with
prostate cancer risk in our study were included in the model.
Certainly, unmeasured or still unknown other factors may have
caused residual confounding. Results after exclusion of cases
detected in the first 2 years of follow-up were similar to those that
included all prostate cancer cases. Therefore, preclinical disease is
not likely to have influenced our results. Finally, chance will have
played a role in our study, in particular because of the multiple
associations that were studied.
Only a minority of previous cohort (Snowdon et al, 1984;
Giovannucci et al, 1993, 1995) and case-control studies (Mettlin et
al, 1989; Talamini et al, 1992; Andersson et al, 1995) had a fairly
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Table 4 Rate ratios (RRs) and 95% confidence intervals (95% CI) for prostate cancer according to quintiles of intake of energy-adjusted calcium and energy-
adjusted protein, for all cases and separately for localized (T0–2, M0) and advanced (T3–4, M0; T0–4, M1) prostate tumours, Netherlands Cohort Study, 6.3
years of follow-up (1986–1992)
Exposure Q1a Q2 Q3 Q4 Q5 P for trend
Calcium
Median intake (mg per day)b 602 780 911 1064 1329
Cases/Person years 120/1821 126/1845 127/1840 140/1817 129/1800
RR (95% CI)c 1.00 1.07 (0.79–1.47) 1.03 (0.75–1.41) 1.20 (0.88–1.64) 1.07 (0.79–1.47) 0.36
RR (95% CI)d 1.00 1.10 (0.80–1.51) 1.04 (0.76–1.42) 1.21 (0.89–1.66) 1.09 (0.79–1.50) 0.34
Localized tumours (n)4 7 3 0 4 54 65 6
RR (95% CI)d 1.00 0.69 (0.42–1.13) 0.96 (0.61–1.50) 1.04 (0.67–1.63) 1.21 (0.79–1.86) 0.10
Advanced tumours (n)4 4 4 6 3 7 4 63 7
RR (95% CI)d 1.00 1.08 (0.69–1.70) 0.79 (0.49–1.27) 1.06 (0.67–1.66) 0.83 (0.52–1.34) 0.45
Total protein
Median intake (g per day)b 62 69 75 81 90
Cases/Person years 128/1839 121/1836 134/1821 135/1792 124/1834
RR (95% CI)c 1.00 1.03 (0.75–1.41) 1.10 (0.81–1.50) 1.31 (0.96–1.79) 1.09 (0.80–1.48) 0.15
RR (95% CI)d 1.00 1.04 (0.76–1.43) 1.12 (0.82–1.53) 1.35 (0.98–1.84) 1.10 (0.81–1.51) 0.11
Localized tumours (n)5 1 3 4 4 04 95 0
RR (95% CI)d 1.00 0.76 (0.47–1.22) 0.87 (0.55–1.38) 1.27 (0.82–1.96) 1.13 (0.73–1.74) 0.13
Advanced tumours (n)4 6 4 3 4 8 3 83 5
RR (95% CI)d 1.00 1.04 (0.66–1.64) 1.08 (0.69–1.69) 1.02 (0.64–1.64) 0.83 (0.51–1.33) 0.49
Vegetable protein
Median intake (g per day)b 22 25 27 30 35
Cases/Person years 143/1827 129/1833 139/1813 110/1812 121/1839
RR (95% CI)c 1.00 0.87 (0.64–1.18) 0.99 (0.74–1.34) 0.83 (0.61–1.13) 0.92 (0.67–1.24) 0.43
RR (95% CI)e 1.00 0.86 (0.63–1.17) 1.00 (0.74–1.36) 0.83 (0.61–1.14) 0.90 (0.66–1.23) 0.37
Localized tumours (n)5 3 4 6 4 23 54 8
RR (95% CI)e 1.00 0.86 (0.55–1.33) 0.85 (0.54–1.33) 0.73 (0.46–1.17) 0.96 (0.62–1.48) 0.63
Advanced tumours (n)3 8 4 3 5 7 3 04 2
RR (95% CI)e 1.00 1.08 (0.67–1.74) 1.55 (0.98–2.44) 0.85 (0.51–1.43) 1.19 (0.74–1.92) 0.81
Animal protein
Median intake (g per day)b 34 42 47 53 64
Cases/Person years 112/1825 137/1843 121/1819 150/1812 122/1823
RR (95% CI)c 1.00 1.21 (0.88–1.65) 1.11 (0.81–1.53) 1.42 (1.04–1.93) 1.16 (0.84–1.59) 0.11
RR (95% CI)e 1.00 1.29 (0.92–1.81) 1.16 (0.80–1.68) 1.52 (1.01–2.30) 1.32 (0.76–2.29) 0.09
Localized tumours (n)4 4 4 0 4 44 55 1
RR (95% CI)e 1.00 0.94 (0.57–1.55) 1.08 (0.64–1.83) 1.13 (0.62–2.05) 1.26 (0.58–2.75) 0.44
Advanced tumours (n)4 3 4 9 4 1 4 73 0
RR (95% CI)e 1.00 1.21 (0.75–1.95) 0.96 (0.56–1.65) 1.11 (0.61–2.04) 0.71 (0.31–1.63) 0.61
aReference category. bMedian intake in subcohort; cut-points calcium 709, 848, 984, 1164; total protein 66, 72, 77, 84; vegetable protein 23, 26, 29, 32; animal
protein 38, 45, 50, 58. cAdjusted for age. dAdjusted for age, family history of prostate cancer, socioeconomic status and total energy intake. eAdjusted for age,
family history of prostate cancer, socioeconomic status, total energy intake and total protein intake.comprehensive measurement of dietary habits. Therefore
(random) misclassification of exposure may have affected results
in earlier studies. Furthermore, results from most other studies
were based on substantially less cases than the total number of
cases in our study. There were only two cohort studies with more
than 400 cases (Giovannucci et al, 1993, 1995; Gronberg et al,
1996) and only three case-control studies with more than 300
cases (Graham et al, 1983; Mettlin et al, 1989; Key et al, 1997).
Comparisons of different studies is also hampered by the fact that
endpoints in previous studies were either incidence or mortality.
Deceased prostate cancer cases may not adequately reflect the
source population of total prostate cancer cases. Finally, limited
adjustment for confounding factors may have influenced results in
different studies.
Total meat consumption or consumption of specific types of
meat were not clearly associated with prostate cancer risk in several
other cohort studies (Snowdon et al, 1984; Mills et al, 1989;
(Severson et al, 1989; Hsing et al, 1990; Giovannucci et al, 1995)
and case-control studies (Schuman et al, 1982; Talamini et al, 1992;
Andersson et al, 1995; Key et al, 1997). On the other hand, positive
associations were observed, in other cohort studies for consump-
tion of meat (Hirayama, 1990), high fat animal products and beef
(Le Marchand et al, 1994), beef, pork and lamb (Giovannucci et al,
1993; Gann et al, 1994), and for meat, poultry and fish (Mills et al,
1989) and in case-control studies for consumption of meat
(Mishina et al, 1985; Talamini et al, 1986; Walker et al, 1992), lamb
and pork (Bravo et al, 1991) and meat and fish combined (Graham
et al, 1983). In other cohort studies inverse associations were
suggested for consumption of beef (Gronberg et al, 1996) and
bacon or side pork (Schuman et al, 1982), and in case-control
studies for consumption of poultry or chicken (Schuman et al,
1982; Ross et al, 1987) and liver (Pawlega et al, 1996).
As in our study, intake of fish was not associated overall with
prostate cancer risk in cohort studies (Severson et al, 1989; Hsing
et al, 1990; Le Marchand et al, 1994; Gronberg et al, 1996), though
a positive (Mills et al, 1989) and an inverse association (Hirayama,
1990) have also been reported. From case-control studies positive
(Andersson et al, 1995), inverse (Schuman et al, 1982; Pawlega et
al, 1996; Key et al, 1997) and null associations (Talamini et al,
1992) have been recorded.
One cohort study reported on processed meats in relation to
prostate cancer risk and in this study no association was found (Le
Marchand et al, 1994). Our data suggested a positive association
between consumption of ‘other sliced cold meats’ and prostate
cancer risk. Although ‘other sliced cold meats’ were not defined
further in our questionnaire, several types of sausages are
frequently consumed in The Netherlands and these products are
most likely to account for the observed association.
In most cohort studies, intake of milk or other dairy products were
not clearly associated with prostate cancer risk (Mills et al, 1989;
Severson et al, 1989; Thompson et al, 1989; Hirayama, 1990; Hsing
et al, 1990; Le Marchand et al, 1994; Giovannucci et al, 1995;
Gronberg et al, 1996); in only one cohort study was a positive asso-
ciation reported (Snowdon et al, 1984). From case-control studies
on milk or dairy products, however, positive associations were
reported more frequently (Mishina et al, 1985; Talamini et al, 1986;
Mettlin et al, 1989; Talamini et al, 1992), although in this type of
study also null associations have been found (Schuman et al, 1982;
Andersson et al, 1995; Ewings and Bowie, 1996). To our knowl-
edge, an (inverse) association between fermented milk products and
prostate cancer risk has not been reported elsewhere, although an
inverse association has been reported in other hormone-related
cancers (Van ‘t Veer et al, 1989).
Consumption of cheese (Snowdon et al, 1984) and cheese in
combination with butter and margarine (Severson et al, 1989) were
associated with a modest increase in risk, in two cohort studies. In
two case-control studies no associations were found (Talamini
et al, 1992; Andersson et al, 1995). Egg consumption was not
associated with prostate cancer risk in all (Snowdon et al, 1984;
Mills et al, 1989 Thompson et al, 1989; Hsing et al, 1990; Le
Marchand et al, 1994; Giovannucci et al, 1995; Gronberg et al,
1996) except one cohort study, in which a positive association was
indicated (Severson et al, 1989). Results from case-control studies
were more diverse, varying from a suggestive inverse association
(Ewings and Bowie, 1996), and null associations (Schuman et al,
1982; Talamini et al, 1992; Andersson et al, 1995) to positive
associations (Ross et al, 1987; Walker et al, 1992).
As in certain other studies (Le Marchand et al, 1994; Andersson
et al, 1995; Giovannucci et al, 1995), we evaluated risk factors sepa-
rately for localized and advanced tumours, though some 30% of our
cases could not be so classified because of missing information on
tumour characterization. The results from our and other studies do
not uniformly point at stronger associations between the exposure
variables and advanced prostate tumours. Because the number of
studies in which subgroup analyses based on tumour characteriza-
tion is low, definite conclusions cannot be drawn yet.
From the results of the NLCS and other studies we conclude
that, thus far, there is no convincing evidence for an important role
of the consumption of fresh meat, fish, cured meat, milk and milk
products, cheese and eggs in prostate cancer aetiology. It has to be
mentioned, however, that even the lower tail of the distribution of
consumption of animal products in the NLCS and in most of the
other studies represents a higher consumption than the average
consumption level in countries with low prostate cancer incidence
rates. Therefore, the possibility that at much lower levels
consumption of animal products is important in prostate cancer
aetiology cannot be ruled out.
In our study we could not confirm a positive association
between calcium intake and prostate cancer risk, which has
recently been proposed (Giovannucci et al, 1998). Furthermore,
there were no clear associations as with animal or vegetable
protein. More studies are needed to investigate the suggested role
of calcium intake in prostate cancer aetiology. Other studies
should also evaluate whether a diet based on animal foods might
be positively associated with prostate cancer risk and whether
plant-based foods might be protective. In future studies, long
follow-up periods with repeated extensive measurements of diet
could be helpful in evaluating whether diet is involved in prostate
cancer progression or whether diet has an effect relatively early in
carcinogenesis. Finally, mechanistic research is also warranted.
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